Here are some key findings: Within six months of starting GLP-1 therapy, the rate of hypotensive events increased from 8.7% to 10.2% The increased risk remained significant at 12 months, with hypotensive events rising from 13.6% to 14.3% Adults age 65 and older accounted for 53% of hypotensive events despite representing 37% of the study population Patients with Type 2 diabetes made up 75% of those experiencing hypotensive episodes but only 63% of the overall cohort In secondary analyses, the scientists found that weight loss alone did not explain the increased risk, suggesting other mechanisms of action may be at play Northwestern Now posed five questions to the study senior author Dr
We vet everything on PubMed so you dont have to
While Viagra has its place and is an easy solution for ED, we offer PT-141 (Bremelanotide), Intracavernous Pharmacotherapy (ICP), and Testosterone Replacement Therapy (TRT) to provide more immediate, long-term solutions to erectile dysfunction
With a commitment to enhancing natural beauty and achieving radiant results, we specialize in treatments that reveal your inherent allure and achieve flawless outcomes
2024;doi:10.1001/jamainternmed.2024.4369
Comprehensive pharmacological profiling of neurofibromatosis cell lines